 Moneycontrol.com | Natco to enter bio-generics; signs up with Mabxience Hindu Business Line Three of these products—Tastuzumab, Bevacizumab and Rituximab — belong to the oncology segment, while Etanercept is for auto-immune disorders. Biogenerics are biopharmaceutical products developed using biological processes. The Hyderabad-based Natco ... Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase ... Natco Pharma inks pact with Mabxience Natco Pharma Signs Pact With Mabxience |
